Hematological Malignancies Diagnosis
Products
Revolution CT
Get uncompromised image quality and clinical capabilities through the convergence of coverage, spatial resolution, temporal resolution and spectral imaging.
SIGNA™ Premier AIR™ Edition
Our leading, innovative 3.0T MRI system brings you uncompromised 60 cm performance in a 70 cm wide bore for advanced imaging and research.
PET/CT
The true potential of PET/CT is its ability to enable a true discovery. A true discovery is different, because it provides reproducible evidence that reveals a greater truth about the human body. A truth that has the ability to not only change the life of one patient, but to transcend an individual to benefit all patients.
Everything we do is with the purpose of providing you with the tools you need to go in search of true discovery. In PET/CT, this means a commitment to making it more accessible and delivering on the promise of personalized care. The result of this commitment is a wide array of technologies designed to help you deliver better patient outcomes.
3. Spleen in hematological malignancies: spectrum of imaging findings. S S Saboo, DNB, FRCR,1 K M Krajewski, MD,1 K N O'Regan, MD,1 A Giardino, MD,1 J R Brown, MD,2 N Ramaiya, MD,1 and J P Jagannathan, MD1. Br J Radiol. 2012 Jan; 85(1009): 81–92.